Opening Recap Market Pulse: Markets drifted into the morning on mixed signals after an EV credit...
Archive - October 3, 2025
IOBT’s Rating Cut: Why You Should Pay Attention Now
Background – Trial Setback and Rating Downgrades IO Biotech (NASDAQ: IOBT) is a clinical-stage...